INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Integra LifeSciences Holdings Corporation

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2024 am IST			5-day change	1st Jan Change
31.65 ^USD	-0.28%		+7.98%	-27.32%

16/07	Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating	MT
15/07	Integra LifeSciences to Shift PriMatrix, SurgiMend Production to New Braintree, Massachusetts Facility by 2026	MT

Integra LifeSciences Holdings Corporation Seeks Acquisitions

January 10, 2018 at 10:30 am IST

Integra LifeSciences Holdings Corporation (NasdaqGS:IART) plans to acquire acquisitions.

Latest news about Integra LifeSciences Holdings Corporation

Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating	16/07	MT
Integra LifeSciences to Shift PriMatrix, SurgiMend Production to New Braintree, Massachusetts Facility by 2026	15/07	MT
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating	15/07	MT
Integra LifeSciences Holdings Corporation Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts	15/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Defensive Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell Midcap Value Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Value Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Value-Defensive Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Dynamic Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell Midcap Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Value Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Dynamic Index	01/07	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to S&P 600 Health Care	24/06	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to S&P 600	24/06	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from S&P 400 Health Care	24/06	CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from S&P 400	24/06	CI
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24	10/06	MT
Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing	25/05	MT
Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing	23/05	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	17/05	MT
Integra LifeSciences Holdings to Repurchase $50 Million in Shares	17/05	MT
Transcript : Integra LifeSciences Holdings Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM	15/05
Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	07/05	MT

Chart Integra LifeSciences Holdings Corporation

Duration

Period

Chart Integra LifeSciences Holdings Corporation

More charts

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Integra LifeSciences Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

31.74 USD

Average target price

35.4 USD

Spread / Average Target

+11.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION	-27.32%	250.11Cr
ABBOTT LABORATORIES	-4.90%	18TCr
MEDTRONIC PLC	-1.36%	10TCr
DEXCOM, INC.	-7.64%	4.62TCr
HOYA CORPORATION	+18.16%	4.48TCr
CENCORA, INC.	+9.63%	4.44TCr
METTLER-TOLEDO INTERNATIONAL, INC.	+13.63%	2.95TCr
TERUMO CORPORATION	+22.31%	2.58TCr
WEST PHARMACEUTICAL SERVICES, INC.	-7.12%	2.4TCr
STERIS PLC	+4.03%	2.25TCr

Other Medical Equipment, Supplies & Distribution